Skip to main content

Table 2 Age and sex-specific prevalence of hypertension in the NCDRI study and the NFHS-5 survey

From: The burden of risk factors for non-communicable disease in rural Bihar, India: a comparative study with national health surveys

Women

Age (years)

NCDRI Study

NFHS-5 Survey

 

N

Hypertension (%)

N

Hypertension (%)

  15–19

  

9338

3.2

  20–24

  

7564

4.7

  25–29

  

6293

6

  30–34

  

5250

8.7

  35–39

197

14.7

4887

12.2

  40–44

168

17.9

3845

17.5

  45–49

147

25.2

3800

23.1

  50–54

162

24.7

  

  55–59

110

34.5

  

  60–64

99

38.4

  

  65–70

122

41.8

  

Overall, not standardized

1005

27.3

40,978

8.9

WHO age standardized at 35–49 years (95%CI)

 

19.0(15.4–23.2)

 

17.3(16.6–18)

Men

Age (years)

NCDRI Study

NFHS-5 Survey

 

N

Hypertension (%)

N

Hypertension (%)

  15–19

  

1038

2.6

  20–24

  

705

7.7

  25–29

  

567

8.4

  30–34

  

494

12.6

  35–39

112

20.5

518

15.2

  40–44

147

17.7

396

19.1

  45–49

162

28.4

434

25.5

  50–54

170

26.5

329

28.5

  55–59

119

35.3

  

  60–64

130

29.2

  

  65–70

185

37.3

  

  Overall, not standardized

1025

27.6

4481

12.3

  WHO age standardized at 35–54 years (95%CI)

 

22.9(19.2–27.3)

 

21.5(19.4–23.9)

  1. Hypertension was defined as a SBP ≥ 140 mmHg or DBP ≥ 90 mmHg at baseline or participants reported receiving blood pressure-lowering medication. Hypertension estimates from the NCDRI Study were adjusted for age and sex, where appropriate. Hypertension estimates from the Bihar State NFHS-5 have been previously published [21]. The age-standardized prevalence estimates from the NCDRI Study and the NFHS-5 Survey were only estimated for overlapping age groups, such that hypertension estimates were calculated for women aged 35–49 and men aged 35–54 years. The age-standardized prevalence estimates were generated by weighting these estimates to the age distribution of the WHO’s standard population [22]